Mechanisms of fatal opioid overdose

被引:442
|
作者
White, JM [1 ]
Irvine, RJ [1 ]
机构
[1] Univ Adelaide, Dept Clin & Expt Pharmacol, Adelaide, SA 5005, Australia
关键词
D O I
10.1046/j.1360-0443.1999.9479612.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
There has been increasing recognition of the problem of fatal opioid overdose. This review examines the pharmacological basis of respiratory depression following opioid administration. Respiration is controlled principally through medullary respiratory centres with peripheral input from chemoreceptors and other sources. Opioids produce inhibition at the chemoreceptors via mu opioid receptors and in the medulla via mu and delta receptors. While there are a number of neurotransmitters mediating the control of respiration, glutamate and GABA are the major excitatory and inhibitory neurotransmitters, respectively. This explains the potential for interaction of opioids with benzodiazepines and alcohol: bath benzodiazepines and alcohol facilitate the inhibitory effect of GABA at the GABA(A) receptor, while alcohol also decreases the excitatory effect of glutamate at NMDA receptors. Heroin and methadone are the major opioids implicated in fatal overdose. Heroin has three metabolites with opioid activity. Variation in the formation of these metabolites due to genetic factors and the use of other drugs could explain differential sensitivity to overdose. Metabolites of methadone contribute little to its action. However, variation in I ate of metabolism due to genetic factors and other drugs used can modify methadone concentration and hence overdose risk. The degree of tolerance also determines risk. Tolerance to respiratory depression is less than complete, and may be slower than tolerance to euphoric and other effects. One consequence of this may be a relatively high risk of overdose among experienced opioid users. While agonist administration modifies receptor function, changes (usually in the opposite direction) also result front use of antagonists. The potential for, supersensitivity to opioids following a period of administration of antagonists such as naltrexone warrants further investigation. While our understanding of the pharmacological basis of opioid-related respiratory depression has advanced, better understanding of the role of heroin metabolites, the metabolism of methadone, drug interactions and tolerance would all be of considerable value in knowing how best to respond to this problem.
引用
收藏
页码:961 / 972
页数:12
相关论文
共 50 条
  • [1] Comments on White & Irvine's "mechanisms of fatal opioid overdose"
    Tagliaro, F
    De Battisti, Z
    [J]. ADDICTION, 1999, 94 (07) : 973 - 974
  • [2] Prevention of Fatal Opioid Overdose
    Beletsky, Leo
    Rich, Josiah D.
    Walley, Alexander Y.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (18): : 1863 - 1864
  • [3] Opioid Prescribing Patterns Before Fatal Opioid Overdose
    Abbasi, Ali B.
    Salisbury-Afshar, Elizabeth
    Berberet, Craig E.
    Layden, Jennifer E.
    Pho, Mai T.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2020, 58 (02) : 250 - 253
  • [5] Informing Physicians of Fatal Overdose Curbs Opioid Prescribing
    Slomski, Anita
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (12): : 1231 - 1231
  • [6] Risks of fatal opioid overdose during the first year following nonfatal overdose
    Olfson, Mark
    Wall, Melanie
    Wang, Shuai
    Crystal, Stephen
    Blanco, Carlos
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2018, 190 : 112 - 119
  • [7] Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone
    Kelty, Erin
    Hulse, Gary
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 46 : 54 - 60
  • [8] Modeling dynamics of fatal opioid overdose by state and across time
    Cooper, R. Lyle
    Thompson, Janese
    Edgerton, Ryan
    Watson, Julia
    MacMaster, Samuel A.
    Kalliny, Medhat
    Huffman, Miranda M.
    Juarez, Paul
    Mathews-Juarez, Patricia
    Tabatabai, Mohammad
    Singh, Karan P.
    [J]. PREVENTIVE MEDICINE REPORTS, 2020, 20
  • [9] Ikke-fatal overdose med nytt syntetisk opioid
    Stangeland, Marcus
    Lunde, Torbjorn
    Fossan, Kjell Ove
    Berg, Jon Andsnes
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2024, 144 (02)
  • [10] Association of Medications for Mood/Anxiety Disorders With Fatal and Non-Fatal Opioid Overdose
    Fairbairn, Nadia
    Crabtree, Alexis
    Schutz, Christian
    Park, Tae Woo
    Socias, Eugenia
    Mok, Janet
    Cui, Zishan
    Ti, Lianping
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2024, 260